Jose Carlos Benitez
@JcbenitezMD
Followers
248
Following
293
Media
26
Statuses
154
Scientist Physician, Lung cancer, MPM & Thymic tumors at HU Virgen de la Victoria. PhD in Translational research program @UniversitatBarcelona. YI LCG @EORTC
Málaga, Spain
Joined November 2018
Very old patients (>80 y) are a neglected population unrepresented&unreported in trials with ICI. Immunesenescence and chronic state of low grade inflammation know as INFLAMAGING expose old pts to higher risk of irAEs as reported in ELDERLY study (1.5% toxic deaths) #WCLC2025
2
31
83
The grant application workshop is in full swing with @ZhaohuiArter leading the way Small group discussions developing different aspects of an application @IASLC @BalazsHalmosMD @LealTiciana @LeiDeng3 @BRicciutiMD @ACortelliniMD @JcbenitezMD @RobertoFerrara_ @CelineMascaux
4
5
27
🧠Do we know enough about TKI pharmacological principles (Tachyphylaxis, interactions..)?🧪 Don’t miss the @EORTC -PAMM joint webinar! 📅 July 22, 6 PM 🔗 Register now to get access: https://t.co/NFtbhOCwKB Let’s close the season with science!☀️🏝️ #EORTClung #LungCancer
0
3
4
🆘 Studies like this are critical. Even negative results contribute valuable biological insight into rare tumors and highlight the need to continue investing in translational research to better understand disease mechanisms and identify future targets.
0
0
0
📉 Although bintrafusp alfa did not meet expected efficacy endpoints, no new safety signals were observed.
1
0
0
📣 Very happy be part of this massive effort of the @gecp_org, key role of @oncomalaga @HUVV_SAS in BIMES clinical trial, assessing bintrafusp alfa in MPM—a rare and challenging disease.⬇️ https://t.co/jNhuNWFYje
lungcancerjournal.info
Pleural mesothelioma (PM) is a rare and aggressive malignancy arising from the mesothelial surface of the pleura [1]. In Europe, the incidence rate per 100 000 persons is 1.7 for males and 0.4 for...
1
1
1
🛎️Don’t miss this interesting webinar on liquid biopsy in lung cancer patients, a joint effort from @EORTC and #ISLB. Dr Simon Heeke will discuss about the role of #liquidbiopsy in #lungcancer. #EORTClung
https://t.co/1U2t6HoF6g
0
1
6
Final presentation of the leadership program within the multidisciplinary lung cancer committee. Amaizing final master class by Jon Segovia de Celaya about team #leadership. Thanks to @deustoDBS and @AstraZenecaES for this opportunity
0
0
8
What happens when Young Lung Cancer minds from @EORTC meet in Paris? Brains, baguettes & bevs at brasserie Circus! 🧠 🥖 🍷 🍻 Science, collaboration and connections with friends beyond the sessions. #EORTClung #ELCC25 #Younginvestigators #LungCancer #EORTC
0
4
16
0
0
0
📡We are delighted to announce th activation of new trial for SCLC pts. We achieved th milestone to be 1️⃣ site in Europe to open MK-6070-002 trial. Very Promosing ✅ MK-6070 (Tcell-recruiting recombinant protein) wth ADC I-DXd (B7-H3) Dont hesitate to contact if any candidate
1
0
0
📚💡 La formación continua es esencial en oncología, pero ¿cómo prefieren recibir la información los especialistas? El Dr. Benítez @JcbenitezMD nos cuenta qué tipo de comunicación prefiere para mantenerse actualizado en su práctica diaria. 🗣️✨ Descubre sus recomendaciones en
0
1
2
Hoy en @DiasDAndalucia con @carmelargarzon hablamos con uno de los premiados y becados de la X Edición de las Becas Gilead a la Investigación Biomédica. El investigador @JcbenitezMD Escúchalo aquí 👇 👉 https://t.co/pFonNCkGCs 👈
canalsur.es
El pasado martes 1 de octubre tuvo lugar la X Edición de las Becas Gilead a la Investigación Biomédica. Hablamos con uno de los becados, el Dr. Jose Carlos Benítez, investigador perteneciente a la...
0
1
3
💥ATENTOS A #ESMO24🔬 ¡Biomarcadores como TROP-2 siguen abriendo camino en el tratamiento del cáncer de pulmón! En #ESMO24, el Dr. Benitez @JcbenitezMD destacó los estudios fase 1 y 2 con anticuerpos conjugados dirigidos a dianas específicas en NSCLC, una opción prometedora para
0
4
6
@myESMO Do we need to press harder in this setting? 🚬 Prevention nd Early Detection are the cure of cancer💡@sanidadgob #lungcancer #smokefreenvironment
0
0
1
Read this interesting review and think about some conclusions ⤵️ @myESMO
https://t.co/MzKLsegP8A
cell.com
Since the early 1990s, the incidence of sporadic early-onset cancers has risen globally, though the underlying reasons remain unclear. Identifying the causes is essential for improving prevention and...
1
0
1
So, very interesting review of its own recommendation by @EU_Commission against Smoking 👍🏼 Nonetheless, we did not get smoke-free environment YET ➡️even after COVID19 measures Bussiness stronger than Health? What about Cancer? How much Cancer cost?🔂⬇️ https://t.co/iJ8Dm3wZqq
ec.europa.eu
Today, the Commission has recommended to better protect people from the effects of second-hand smoke and aerosols through the revision of the Council Recommendation on smoke-free environments.
1
0
5
🌟 El Dr. Benitez @JcbenitezMD presenta en #ESMO24 la metodología y los resultados de eficacia y seguridad del ensayo clínico fase 1 REGN5093 con davutamig. 🧬 Este prometedor tratamiento ofrece una nueva esperanza para pacientes con cáncer de pulmón que no tiene control. 💡 🔍
0
1
1
Happy to share our new open access article on microbiome and lung cancer! Looking forward to reading your comments and suggestions . @mayluciemeyer @JcbenitezMD
https://t.co/hD8X1uPMCg
tlcr.amegroups.org
Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review
0
2
5
